{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:41:24Z","timestamp":1790606484217,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.critrevonc.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:36:55Z","timestamp":1513172215000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis"],"prefix":"10.1016","volume":"122","author":[{"given":"Sara","family":"Gandini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Palli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spadola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bendinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cocorocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Stanganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Miligi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Caini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.critrevonc.2017.12.003_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1586\/17469872.2.4.451","article-title":"Mechanism of UV-related carcinogenesis and its contribution to nevi\/melanoma","volume":"2","author":"Anna","year":"2007","journal-title":"Expert Rev. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.12.003_bib0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(02)00157-0","article-title":"Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study","volume":"39","author":"Beiderbeck-Noll","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0020","doi-asserted-by":"crossref","first-page":"e4757","DOI":"10.1136\/bmj.e4757","article-title":"Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis","volume":"345","author":"Boniol","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.12.003_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10552-010-9697-0","article-title":"Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study","volume":"22","author":"Borena","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"27","key":"10.1016\/j.critrevonc.2017.12.003_bib0030","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","article-title":"Propranolol reduces cancer risk: a population-based cohort study","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"10.1016\/j.critrevonc.2017.12.003_bib0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","volume":"100","author":"Christian","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.12.003_bib0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archinternmed.2011.131","article-title":"Treatment with \u03b2-blockers and reduced disease progression in patients with thick melanoma","volume":"171","author":"De Giorgi","year":"2011","journal-title":"Arch. Intern. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.12.003_bib0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2013.09.001","article-title":"Effect of \u03b2-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death","volume":"88","author":"De Giorgi","year":"2013","journal-title":"Mayo Clin. Proc."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.12.003_bib0050","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/jid.2012.227","article-title":"Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial","volume":"132","author":"Dyer","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.12.003_bib0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","article-title":"A review of human carcinogens\u2013part D: radiation","volume":"10","author":"El Ghissassi","year":"2009","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.12.003_bib0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953\u20132008\u2013are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.12.003_bib0065","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","article-title":"Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark","volume":"92","author":"Friis","year":"2001","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.critrevonc.2017.12.003_bib0070","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.12.003_bib0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose-response data, with applications to meta-analysis","volume":"135","author":"Greenland","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","article-title":"Quantitative methods in the review of epidemiologic literature","volume":"9","author":"Greenland","year":"1987","journal-title":"Epidemiol. Rev."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.12.003_bib0095","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2165\/11589300-000000000-00000","article-title":"Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature","volume":"29","author":"Guy","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.12.003_bib0100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"6878","key":"10.1016\/j.critrevonc.2017.12.003_bib0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.306.6878.609","article-title":"Incidence of and mortality from cancer in hypertensive patients","volume":"306","author":"Hole","year":"1993","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","article-title":"Cancer risk of hypertensive patients taking calcium antagonists","volume":"16","author":"Hole","year":"1998","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.12.003_bib0115","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaad.2014.07.003","article-title":"Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989","volume":"71","author":"Hollestein","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.12.003_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bjd.12346","article-title":"Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991","volume":"169","author":"Holterhues","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0125","series-title":"Monographs on the Evaluation of Carcinogenic Risks to Humans. Solar and Ultraviolet Radiation","author":"International Agency for Research on Cancer (IARC)","year":"2017"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.12.003_bib0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.27740","article-title":"Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series","volume":"119","author":"Jahan-Tigh","year":"2013","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6604686","article-title":"Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study","volume":"99","author":"Jensen","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.12.003_bib0140","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-10-0652","article-title":"Photosensitizing medication use and risk of skin cancer","volume":"19","author":"Kaae","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"Pt. A","key":"10.1016\/j.critrevonc.2017.12.003_bib0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jsbmb.2013.10.019","article-title":"Modifiable risk factors including sunlight exposure and fish consumption are associated with risk of hypertension in a large representative population from Macau","volume":"144","author":"Ke","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.12.003_bib0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.canep.2009.10.005","article-title":"Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"33","author":"Koomen","year":"2009","journal-title":"Cancer Epidemiol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.12.003_bib0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.annepidem.2007.01.030","article-title":"Ambient UVB and melanoma risk in the United States: a case-control analysis","volume":"17","author":"Lea","year":"2007","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5487\/TR.2017.33.1.043","article-title":"Phototoxicity evaluation of pharmaceutical substances with a reactive oxygen species assay using ultraviolet A","volume":"33","author":"Lee","year":"2017","journal-title":"Toxicol. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.12.003_bib0165","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","article-title":"\u03b2-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study","volume":"20","author":"Lemeshow","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"9123","key":"10.1016\/j.critrevonc.2017.12.003_bib0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.12.003_bib0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.jhh.1001834","article-title":"Cancer pattern among hypertensive patients in North Karelia, Finland","volume":"19","author":"Lindgren","year":"2005","journal-title":"J. Hum. Hypertens."},{"issue":"9281","key":"10.1016\/j.critrevonc.2017.12.003_bib0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(01)05704-X","article-title":"Relation between drug treatment and cancer in hypertensives in the Swedish trial in old patients with hypertension 2: a 5-year, prospective, randomised, controlled trial","volume":"358","author":"Lindholm","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.12.003_bib0185","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.12.003_bib0190","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.12.003_bib0195","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1055-9965.EPI-14-0251","article-title":"Prescription diuretic use and risk of basal cell carcinoma in the nationwide US radiologic technologists cohort","volume":"23","author":"McDonald","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2015.11.026","article-title":"The burden of malignant melanoma\u2013lessons to be learned from Austria","volume":"56","author":"Monshi","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.12.003_bib0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clindermatol.2016.05.006","article-title":"Drug-induced photosensitivity: photoallergic and phototoxic reactions","volume":"34","author":"Monteiro","year":"2016","journal-title":"Clin. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.12.003_bib0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5414\/CNP73439","article-title":"Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients","volume":"73","author":"Moscarelli","year":"2010","journal-title":"Clin. Nephrol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.12.003_bib0215","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.mayocp.2014.06.001","article-title":"Effect of \u03b2-adrenergic blockers and other antihypertensive drugs on the risk of melanoma recurrence and death-I","volume":"89","author":"Moser","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2133.2012.10974.x","article-title":"Metabolic risk factors and skin cancer in the metabolic syndrome and cancer project (Me-Can)","volume":"167","author":"Nagel","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.12.003_bib0225","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40264-016-0487-9","article-title":"Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study","volume":"40","author":"Nardone","year":"2017","journal-title":"Drug Saf."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.12.003_bib0230","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.HYP.29.5.1091","article-title":"Cancer risk in users of calcium channel blockers","volume":"29","author":"Olsen","year":"1997","journal-title":"Hypertension"},{"issue":"9026","key":"10.1016\/j.critrevonc.2017.12.003_bib0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","article-title":"Calcium-channel blockade and incidence of cancer in aged populations","volume":"348","author":"Pahor","year":"1996","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.critrevonc.2017.12.003_bib0240","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.110.007336","article-title":"Use of angiotensin receptor blockers and the risk of cancer","volume":"123","author":"Pasternak","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1039\/C1PP05144J","article-title":"UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer","volume":"11","author":"Pfeifer","year":"2012","journal-title":"Photochem. Photobiol. Sci."},{"issue":"19","key":"10.1016\/j.critrevonc.2017.12.003_bib0250","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJM199911043411915","article-title":"Association between actinic keratoses and potentially photosensitizing drugs","volume":"341","author":"Placzek","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0255","series-title":"A Revised Tool to Assess Risk of Bias in Randomized Trials","author":"RoB 2.0 tool","year":"2017"},{"issue":"13","key":"10.1016\/j.critrevonc.2017.12.003_bib0260","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","article-title":"Calcium channel blockers and the risk of cancer","volume":"279","author":"Rosenberg","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.12.003_bib0265","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00004872-199816070-00006","article-title":"Hypertension and long-term cancer incidence and mortality among Swedish men","volume":"16","author":"Rosengren","year":"1998","journal-title":"J. Hypertens."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.12.003_bib0270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/jhh.2009.21","article-title":"Angiotensin inhibition and malignancies: a review","volume":"23","author":"Rosenthal","year":"2009","journal-title":"J. Hum. Hypertens."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.12.003_bib0275","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1097\/HJH.0000000000001018","article-title":"Associations of blood pressure, sunlight, and vitamin D in community-dwelling adults","volume":"34","author":"Rostand","year":"2016","journal-title":"J. Hypertens."},{"issue":"13","key":"10.1016\/j.critrevonc.2017.12.003_bib0280","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.ejca.2010.04.024","article-title":"High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study","volume":"46","author":"Ruiter","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.12.003_bib0285","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9149(99)00113-7","article-title":"Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial","volume":"83","author":"Sajadieh","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.12.003_bib0290","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jdv.12921","article-title":"Use of antihypertensive drugs and risk of skin cancer","volume":"29","author":"Schmidt","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.12.003_bib0295","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00228-013-1476-x","article-title":"Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma","volume":"69","author":"Siiskonen","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.12.003_bib0300","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0305","doi-asserted-by":"crossref","first-page":"e54242","DOI":"10.1371\/journal.pone.0054242","article-title":"Total serum cholesterol and cancer incidence in the metabolic syndrome and cancer project (Me-Can)","volume":"8","author":"Strohmaier","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.critrevonc.2017.12.003_bib0310","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0315","series-title":"Risk Of Bias in Non-randomized Studies \u2212of Interventions","author":"The ROBINS-I tool","year":"2017"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2017.12.003_bib0320","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.2012.11085.x","article-title":"Risk factors for actinic keratosis in eight European centres: a case-control study","volume":"167","author":"Traianou","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"26","key":"10.1016\/j.critrevonc.2017.12.003_bib0325","doi-asserted-by":"crossref","first-page":"e4070","DOI":"10.1097\/MD.0000000000004070","article-title":"Risk of skin cancer in patients with diabetes mellitus: a nationwide retrospective cohort study in Taiwan","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.12.003_bib0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/pubmed\/fdt032","article-title":"Measuring current and future cost of skin cancer in England","volume":"36","author":"Vallejo-Torres","year":"2014","journal-title":"J. Public Health (Oxf.)"},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0335","series-title":"Photosensitizing Medication List","author":"Vitiligo Support International","year":"2017"},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0340","doi-asserted-by":"crossref","first-page":"e5909","DOI":"10.1136\/bmj.e5909","article-title":"Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis","volume":"345","author":"Wehner","year":"2012","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.12.003_bib0345","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.1996.216","article-title":"Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors","volume":"73","author":"Westerdahl","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.12.003_bib0350","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2013.35","article-title":"Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial","volume":"133","author":"Xiong","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.critrevonc.2017.12.003_bib0355","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0076-6879(00)19035-4","article-title":"Photocarcinogenesis UVA vs UVB","volume":"319","author":"de Gruijl","year":"2000","journal-title":"Methods Enzymol."},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2017.12.003_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2012.11081.x","article-title":"Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study","volume":"167","author":"de Vries","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.12.003_bib0365","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/sim.1040","article-title":"Advanced methods in meta-analysis: multivariate approach and meta-regression","volume":"21","author":"van Houwelingen","year":"2002","journal-title":"Stat. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817303165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817303165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T04:22:45Z","timestamp":1535170965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817303165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":73,"alternative-id":["S1040842817303165"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.12.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}